Interleukin-7 and lymphopoiesis: biological and clinical implications.
Appasamy
P M
PM
Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pennsylvania 15213, USA.
D000818:Animals; D015703:Antigens, CD / Q000737:chemistry / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D001921:Brain / Q000187:drug effects; D005786:Gene Expression Regulation; D015316:Genetic Therapy; D006410:Hematopoiesis / Q000187:drug effects / Q000502:physiology*; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016219:Immunotherapy, Adoptive; D007239:Infections / Q000503:physiopathology; D015851:Interleukin-7 / Q000235:genetics / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D007963:Leukocytes, Mononuclear / Q000166:cytology; D008214:Lymphocytes / Q000166:cytology*; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D008954:Models, Biological; D009374:Neoplasms, Experimental / Q000188:drug therapy; D015213:Neuroimmunomodulation / Q000502:physiology; D018123:Receptors, Interleukin / Q000737:chemistry / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D020395:Receptors, Interleukin-7; D011993:Recombinant Fusion Proteins / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D014162:Transfection
D015703:Antigens, CD; D007155:Immunologic Factors; D015851:Interleukin-7; D018123:Receptors, Interleukin; D020395:Receptors, Interleukin-7; D011993:Recombinant Fusion Proteins